Is Kaleido Biosciences, Inc. (KLDO) a Buy, Sell, or Hold?
OTC : KLDO
Kaleido Biosciences, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 1.06K
- Average Volume
- 1.48K
- Market Capitalization
- $4.26K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.20
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.43
Company Overview
OTC
Mark A. Wingertzahn
Biotechnology
Healthcare
KLDO
76
US
USD
Liquidity Metrics
2.05
1.43
1.43
1.30
0.00
Sales & Valuation
$1.1M
0.00
0.00
0.00
-1.87
Profitability
-$2.16
-$90.29M
-8178.26%
-8178.26%
-580.57%
-180.08%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
7 Analysts
%
Financial Health Scores
-15.62
3/9
$12.63M
$50.14M
$39.53M
-$87.63M
Key Metrics (TTM)
-$16.78M
-15.20
0.20
1.43
-580.57%
-239.53%
-2156904.33%
-1835358.99%
-878 days
Company Executives
| Name | Title |
|---|---|
| Mark A. Wingertzahn | Senior Vice President of R&D and Head of Development |
Poll Results
No votes yet today — be the first to share your view!
About Kaleido Biosciences, Inc. (OTC:KLDO) Stock
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts. ...
Frequently Asked Questions
-
What is the current Kaleido Biosciences, Inc. (KLDO) stock price?
-
Kaleido Biosciences, Inc.(OTC:KLDO) stock price is $0.0001 in the last trading session. During the trading session, KLDO stock reached the peak price of $0.20005 while $0.00001 was the lowest point it dropped to. The percentage change in KLDO stock occurred in the recent session was 0.0% while the dollar amount for the price change in KLDO stock was $0.
-
KLDO's industry and sector of operation?
-
The OTC listed KLDO is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of KLDO?
-
Mark A. Wingertzahn | Senior Vice President of R&D and Head of Development
|
|
|
| -
How many employees does KLDO have?
-
Number of KLDO employees currently stands at 76. KLDO operates from 65 Hayden Avenue, Lexington, MA 02421, US.
-
Link for KLDO official website?
-
Official Website of KLDO is: https://kaleido.com
-
How do I contact KLDO?
-
KLDO could be contacted at phone #617 674 9000 and can also be accessed through its website. KLDO operates from 65 Hayden Avenue, Lexington, MA 02421, US.
-
How many shares of KLDO are traded daily?
-
The average number of KLDO shares traded daily for last 3 months was 1.48K.
-
What is the market cap of KLDO currently?
-
The market value of KLDO currently stands at $4.26K with its latest stock price at $0.0001